"Natural products are still key sources of current clinical drugs and innovative therapeutic agents. Since wild-type microorganisms only produce natural products in very small quantities, yields of production strains need to be improved by breaking down the precise genetic and biochemical circuitry. Herein, we use avermectins as an example of production improvement and chemical structure diversification by synthetic biology. Avermectins are macrocyclic lactones produced by Streptomyces avermitilis and are well known and widely used for antiparasitic therapy. Given the importance of this molecule and its derivatives, many efforts and strategies were employed to improve avermectin production and generate new active analogues. This review describes the current status of synthetic strategies successfully applied for developing natural-product-producing strains and discusses future prospects for the application of enhanced avermectin production."
As part of a major new initiative by President Michael D. Higgins, Science Gallery at Trinity College Dublin will explore the ethics and future directions of...
Get the latest in biotechnology through daily news coverage as well as analysis, features, tutorials, webinars, podcasts, and blogs. Learn about the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.
Gideon Rose, Editor of Foreign Affairs, interviews Laurie Garrett, senior fellow at the Council on Foreign Relations, on the promise and perils of synthetic ...
"We present a critical review of recent work related to the assembly of multicompartment liposome clusters using nucleic acids as a specific recognition unit to link liposomal modules. The asymmetry in nucleic acid binding to its non-self complementary strand allows the controlled association of different compartmental modules into composite systems. These biomimetic multicompartment architectures could have future applications in chemical process control, drug delivery and synthetic biology. We assess the different methods of anchoring DNA to lipid membrane surfaces and discuss how lipid and DNA properties can be tuned to control the morphology and properties of liposome superstructures. We consider different methods for chemical communication between the contents of liposomal compartments within these clusters and assess the progress towards making this chemical mixing efficient, switchable and chemically specific. Finally, given the current state of the art, we assess the outlook for future developments towards functional modular networks of liposomes."
"Synthetic biology is the science of reassembling cataloged and standardized biological items in a systematic and rational manner to create and engineer functional biological designer devices, systems and organisms with novel and useful, preferably therapeutic functions. Synthetic biology has significantly advanced the design of complex genetic networks that can reprogram metabolic activities in mammalian cells and provide novel therapeutic strategies for future gene-based and cell-based therapies. Synthetic biology-inspired therapeutic strategies provide new opportunities for improving human health in the 21st century. This review covers the most recent synthetic mammalian circuits designed for therapy of diseases such as metabolic disorders, cancer, and immune disorders. We conclude by discussing current challenges and future perspectives for biomedical applications of synthetic mammalian gene networks."
For the fourth entry in the series, I will not introduce one, but two papers, published back to back in a January 2000 issue of Nature. The particularity of these articles is not that the described...
"Cells proliferate by division into similar daughter cells, a process that lies at the heart of cell biol- ogy. Extensive research on cell division has led to the identification of the many components and control ele- ments of the molecular machinery underlying cellular division. Here we provide a brief review of prokaryotic and eukaryotic cell division and emphasize how new approa- ches such as systems and synthetic biology can provide valuable new insight."
Microsoft Research's Andy Wilson demonstrates a 'touch-screen' projector on Joshua Topolsky's back. Microsoft will aim to make all of its scientific research publicly accessible in a move to...
"In the not too distant future, we could see cyborg plants that tell us when they need more water, what chemicals they’ve been exposed to, and what parasites are eating their roots. These part-organic, part-electronic creations may even tell us how much pollution is in the air. And yes, they’ll plug into the network.
That’s right: We’re on our way to the Internet of Plants.
That’s the message from Andrea Vitaletti, the head of a blue-sky research group working on this very thing at a lab in Italy. The project is called PLEASED, short for “PLants Employed As SEnsing Devices.” Though the project is still in the early stages, Vitaletti believes plants could serve as ideal sensors, monitoring so many aspects of our environment. Plants are cheap and resilient, he argues, and they could potentially monitor many different things simultaneously.
“Plants have millions of years of evolution. They are robust. They want to survive,” Vitaletti says...."
an important cellular reprogramming paper: "which requires neither nuclear transfer nor the introduction of transcription factors"
*Stimulus-triggered fate conversion of somatic cells into pluripotency*
by Haruko Obokata,Teruhiko Wakayama,Yoshiki Sasai,Koji Kojima,Martin P. Vacanti,Hitoshi Niwa,Masayuki Yamato& Charles A. Vacanti
"Here we report a unique cellular reprogramming phenomenon, called stimulus-triggered acquisition of pluripotency (STAP), which requires neither nuclear transfer nor the introduction of transcription factors. In STAP, strong external stimuli such as a transient low-pH stressor reprogrammed mammalian somatic cells, resulting in the generation of pluripotent cells. Through real-time imaging of STAP cells derived from purified lymphocytes, as well as gene rearrangement analysis, we found that committed somatic cells give rise to STAP cells by reprogramming rather than selection. STAP cells showed a substantial decrease in DNA methylation in the regulatory regions of pluripotency marker genes. Blastocyst injection showed that STAP cells efficiently contribute to chimaeric embryos and to offspring via germline transmission. We also demonstrate the derivation of robustly expandable pluripotent cell lines from STAP cells. Thus, our findings indicate that epigenetic fate determination of mammalian cells can be markedly converted in a context-dependent manner by strong environmental cues."
An enthusiastic group of non-experts, working through an online interface and receiving feedback from lab experiments, has produced designs for RNA molecules that are consistently more successful than those generated by the best computerized design algorithms, researchers report.
"In an effort to build a nanoscale DNA sequencer, IBM scientists are drilling nano-sized holes in computer-like chips and passing DNA strands through them in order to read the information contained within their genetic code.
This research effort is to design a silicon-based DNA Transistor that could help pave the way to easily and quickly read human DNA, generating advancements in health condition diagnosis and treatment. The challenge in the effort is to slow the flow of the DNA through the hole so the reader can accurately decode what is in the DNA. If successful, the project could improve throughput and reduce cost to achieve the vision of personalized genome analysis at a cost of $100 to $1,000. In comparison, the first sequencing ever done by the Human Genome Project (HGP) cost $3 billion.A human genome sequencing capability affordable for individuals is the ultimate goal of the DNA sequencing and is commonly referred to as $1,000 genome. Ultimately, it can improve the quality of medical care by identifying patients who will gain the greatest benefit from a particular medicine and those who are most at risk of adverse reactions."
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.
by
"Natural products are still key sources of current clinical drugs and innovative therapeutic agents. Since wild-type microorganisms only produce natural products in very small quantities, yields of production strains need to be improved by breaking down the precise genetic and biochemical circuitry. Herein, we use avermectins as an example of production improvement and chemical structure diversification by synthetic biology. Avermectins are macrocyclic lactones produced by Streptomyces avermitilis and are well known and widely used for antiparasitic therapy. Given the importance of this molecule and its derivatives, many efforts and strategies were employed to improve avermectin production and generate new active analogues. This review describes the current status of synthetic strategies successfully applied for developing natural-product-producing strains and discusses future prospects for the application of enhanced avermectin production."
http://bit.ly/1eQL0c7